Company profile for Oncoceutics Inc

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Oncoceutics, Inc. is a clinical-stage drug discovery and development company with a novel class compounds that selectively target G protein-coupled receptors for oncology. The first lead compound to result from this program is ONC201.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
3624 Market Street University City Science Center, Suite 5E Philadelphia, PA 1...
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://oncoceutics.com/oncoceutics-receives-foundation-grants-to-establish-an-expanded-access-program-for-onc201/#:~:text=Philadelphia%2C%20PA%20(November%205%2C,ONC201%20in%20the%20United%20States.

PRESS RELEASE
09 Nov 2020

https://oncoceutics.com/oncoceutics-begins-clinical-trial-with-next-generation-imipridone-onc206-at-the-nih/

PRESS RELEASE
28 Oct 2020

https://oncoceutics.com/oncoceutics-expands-ip-portfolio-with-additional-patents-for-onc201-and-onc212/

PRESS RELEASE
13 Oct 2020

https://oncoceutics.com/oncoceutics-to-present-additional-data-at-asco-showing-clinical-benefit-from-onc201-for-cancer-patients/

ONCOCEUTICS
30 May 2020

https://oncoceutics.com/phase-i-ii-clinical-study-of-onc201-begins-in-japan/

ONCOCEUTICS
01 Apr 2020

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty